Ledger.Open graph →
SEC Form D · Amendment · filed July 8, 2020

CARISMA Therapeutics Inc

Offering
$52.9M
Sold
$52.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Steven Kelly · Philadelphia, PAExec · DirectorJacob Gunterberg · Philadelphia, PADirectorMargarita Chavez · Philadelphia, PADirectorRegina Hodits · Philadelphia, PADirectorEran Nadav · Canton, MADirectorAlthea Stillman · Philadelphia, PADirectorTony Padgett · San Antonio, TXDirectorMike Kienitz · San Antonio, TXExec · DirectorRobert Scofield · San Antonio, TXDirectorMarty Neese · SAN ANTONIO, TXDirectorLaura Velarde · San Antonio, TXDirectorDan Rabinowitz · San Antonio, TXDirectorBrennen Degner · PLAYA VISTA, CADirectorPatrick Reilly · Brighton, MAExec · DirectorDevin Antin · PLAYA VISTA, CADirectorRishi Srivastava · Franklin Lakes, NJDirectorMadhav Krishna · Franklin Lakes, NJDirectorSuren Dutia · Franklin Lakes, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗